Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 12.70
Change Today -6.30 / -33.16%
Volume 6.0
GEFEN On Other Exchanges
Tel Aviv
As of 3:15 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dan S. Suesskind

Former Director and Member of Investment Committee, Gefen Biomed Investments Ltd
AgeTotal Calculated CompensationThis person is connected to 67 board members in 7 different organizations across 12 different industries.

See Board Relationships


Mr. Dan S. Suesskind served as the Chief Financial Officer of Teva Pharmaceutical Finance LLC, the holding company of Teva Pharmaceuticals USA Inc. from 1978 to 2008. Mr. Suesskind served as the Chief Financial Officer of Teva Pharmaceutical Industries Ltd. from 1978 to 2008 and also served as its Financial Manager. He served at Teva Pharmaceutical Industries Ltd. since 1976. He had played a pivotal role in the strategic activities of the Israeli generic pharmaceuticals ...

Read Full Background

Corporate Headquarters*

Tzomet Abba Hillel
Ashkelon, -- 78172


Phone: 972 8 675 1122
Fax: 972 8 675 1113

Board Members Memberships*

Independent Director, Member of Audit Committee and Member of Stock Option & Compensation Committee
External Director, Member of Audit Committee and Member of Compensation Committee
Independent Director
Director, Member of Audit Committee and Member of Investment Committee


MBA 1969
University Of Massachusetts
BA 1965
Hebrew University of Jerusalem

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEFEN:IT 12.70 -6.30


François Adrianus Van Houten Chairman of the Board of Management, Chief Executive Officer and Member of the Executive Committee
Koninklijke Philips N.V
Kelvyn H. Cullimore Jr.Chairman, Chief Executive Officer and President
Dynatronics Corp.
Hae-Ryung Hwang Chief Executive Officer
Lutronic Corporation
Mark J. Foley Chief Executive Officer, President and Director
ZELTIQ Aesthetics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GEFEN BIOMED INVESTMENT LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at